TrialNature communications2024

Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial.

Manabu Shiozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.